¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anticoagulant citrate dextrose solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bromine solution
    ºê·Ò¿ë¾×
  • buffer solution
    ¿ÏÃæ¾×
  • Burow¡¯s solution
    ºÎ·Î¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×
  • crystalloid solution
    °áÁ¤Áú¿ë¾×
  • culture solution
    ¹è¾ç¾×
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×
  • disclosing solution
    1. Ä¡ÅÂÂø»ö¾× 2. ³ëÃâ¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
  • hypotonic solution
    ÀúÀå¾×
  • heavy solution
    Áß¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • buffer solution
    ¿ÏÃæ¾×
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×, ½ÉÀ帶ºñ¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×, ±³Áú¿ë¾×
  • conjugate solution
    ¦¿ë¾×
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×
  • equimolecular solution
    µîºÐÀÚ¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • heavy solution
    Áß¾×
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×, ³ôÀº»ïÅõ¾Ð¿ë¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Hanks solution
    ÇÚÅ©¿ë¾×
  • Hanks solution
    ÇàÅ© ÆòÇü¿°¿ë¾×
  • Hartmann s hypotonic solution
    Çϸ£Æ®¸¸ÀúÀå¾×.
  • Hayem s solution
    ¾ÆÀ̾ä¿ë¾×.
  • Heidenhain s hematoxylin staining solution
    ÇÏÀ̵§ÇÏÀÎ Ç츶Åå½Ç¸° ¿°»ö¾×.
  • Locke s solution
    ·ÎÅ©¾×.
  • Lockes solution
    ·ÎÅ©¾×
  • Lockes solution
    ·ÎÅ©¾×(¡­äû).
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lupus anticoagulant
    ·çǪ½ºÇ×ÀÀ°í¹°Áú
  • lupus anticoagulant
    ·çǪ½ºÇ×ÀÀ°íÀÎÀÚ
  • lupus anticoagulant
    ·çÇÁ½º Ç×ÀÀ°íÁ¦(¡­ ù÷ëêͳð¥)
  • lupus anticoagulant syndrome
    ·çÇÁ½º Ç×ÀÀ°íÁ¦ ÁõÈıº
  • lupus-like anticoagulant
    ·çǪ½º¾ç Ç×ÀÀ°íÀÎÀÚ
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(ÌèÏ¢ù÷ ëêúìå·).
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(˭˴̰ ËôÌ´Ëâ).
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(ÌèÏ¢ù÷ëêúìå·).
  • citrate
    ±¸¿¬»ê¿°
  • citrate
    ±¸¿¬»ê
  • citrate intoxication
    ±¸¿¬»êÁßµ¶(Áõ).
  • citrate test
    ±¸¿¬»ê¿°(ÀÌ¿ë)½ÃÇè, ½ÃÆ®¸£»ê½ÃÇè.
  • citrate toxicity
    ±¸¿¬»êµ¶¼º
  • citrate utilization test
    ±¸¿¬»êÀÌ¿ë½ÃÇè
  • desoxycholate citrate agar
    µ¥¿Á½ÃÄÝ»ê ½ÃÆ®¸£»ê ÇÑõ(¡­ß«ùÎô¸).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • concentrated solution
    ³óÃà¾×(ÒØõêäû)
  • Denhart's solution
    µ§Çϸ£Æ® ¿ë¾×(éÁäû)
  • dilute solution
    Èñ¼®¿ë¾×(ýüà·éÁäû)
  • formal solution
    Æ÷¸£¸» ¿ë¾×(éÁäû)
  • Huebl's iodine solution
    ÈÖºí ¿ä¿Àµå¿ë¾×(éÁäû)
  • hypertonic solution
    °íÀå¾×(ÍÔíåäû)
  • hypotonic solution
    ÀúÀå¾×(î¸íåäû)
  • ideal solution
    ÀÌ»ó ¿ë¾×(×âßÌéÁäû)
  • isoosmolar solution
    µîÀå¾×(Ôõíåäû)
  • isosmotic solution
    µî»ïÅõ¾×(Ôõß¶÷âäû)
  • isotonic solution
    µîÀå¾×(Ôõíåäû)
  • Knop's solution
    Å©³ô¿ë¾×(éÁäû)
  • Krebs-Ringer solution
    Å©·¾½º-¸µ°Å ¿ë¾×(éÁäû)
  • Locke's solution
    ·Ï ¿ë¾×(éÁäû)
  • Lugol's solution
    ·ç°ñ ¿ë¾×(éÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPDA citrate-phosphate-dextrose-adenine
PCD pacer-cardioverter-defibrillator; papillary collecting duct; paraneoplastic cerebellar degeneration;...
D-5-HS 5% dextrose in Harman's solution
D/LR dextrose in lactated Ringer solution
D5LR dextrose in 5% lactated Ringer solution
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AC Anticoagulant
LAC Lupus AntiCoagulant
OAC Oral anticoagulant
OAT Oral anticoagulant therapy
r-TAP Recombinant tick anticoagulant peptide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • boric acid solution
    ºØ»ê ¼ö
  • cardioplegic solution
    ½É Á¤Áö ¿ë¾×
  • Carnoy's solution
    Carnoy ¿ë¾×
  • cleansing solution
    ûÁ¤ ¾×, ÀÇÄ¡ û°á ¿ë¾×
  • conjugate solution
    ¦ ¿ë¾×
  • developing solution
    Çö»ó ¾×
  • diluted ammonia solution
    Èñ¼® ¾Ï¸ð´Ï¾Æ¼ö
    ¹«»ö Åõ¸íÇÑ ¾ËÄ®¸®¼º ¿ë¾×. 100ml Áß¿¡ 9¡­10gÀÇ ¾Ï¸ð´Ï¾Æ¸¦ ÇÔÀ¯ÇÑ´Ù. Á¦¾à¿¡ ÇʼöÀûÀ¸·Î »ç¿ëµÈ´Ù.
  • disclosing solution
    Ä¡ÅÂ Âø»ö¾×
    Ä¡¾Æ Ç¥¸é¿¡ ¹ß¶ó¼­ ¼úÀÚ ¶Ç´Â ȯÀÚ°¡ ±× Ç¥¸é¿¡ ºÙ¾î ÀÖ´Â Ä¡¼®À̳ª ±âŸ Ä§Âø¹°À» º¼ ¼ö ÀÖµµ·Ï Á¶¼ºµÈ ¿ë¾×.
  • equimolecular solution
    µîºÐÀÚ ¿ë¾×
  • firing solution
    °íÁ¤¾×, Á¤Âø¾×
  • Harlmann sodium lactate solution
    Á¥»ê ³ªÆ®·ý ¿ë¾×, Çϸ£Æ®¸¸ ¿ë¾×, À¯»ê ³ªÆ®·ý ¿ë¾×
  • Hawship's solution
    ¾ÆÀÌ¾ä ¿ë¾×
  • hydrogen peroxide solution
    °ú»êÈ­ ¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¾×
    ±âÁؾ׺¸´Ù ´õ Å« ºñÁßÀ» °®´Â ¿ë¾×. ¿¹¸¦ µé¸é ô¼ö ¸¶ÃëÁ¦·Î ô¼ö¾×ÀÇ ºñÁߺ¸´Ù Å« ºñÁßÀ» °®´Â ¾×ÀÌ ÁÖ»çµÇ¸é ÁÖ»ç ºÎÀ§ ¾Æ·¡ÂÊÀ¸·Î µµ´ÞÇÏ¿© ÀÌ ºÎÀ§°¡ ¸¶ÃëµÈ´Ù.
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
gallium-67 citrate <radiology> Analogue of ferric iron, decay: by electron capture to ground state of Zn-67, energy levels: 92 KeV (40%); 184 KeV (23%); 296 KeV (21%), physiological half life: 3.3 days (78 hr), biological half life: 2-3 weeks, binding sites: serum: transferrin, haptoglobin, albumin, globulins, tissue: lactoferrin, PMN's (viable and nonviable), lymphocytes, macrophages, bacteria and fungi, tumour cell-associated transferrin receptor see: gallium: indications
(12 Dec 1998)
magnesium citrate Mg3(C6H5O7)2-14H 2O;a laxative; usually administered as an effervescent flavored beverage.
(05 Mar 2000)
chlorothen citrate Chloromethapyrilene citrate; N,N-dimethyl-N'-(2-pyridyl)-N'-(5-chloro-2-thenyl)ethylenediamine citrate;an antihistaminic agent.
(05 Mar 2000)
choline dihydrogen citrate <chemical> A lipotropic agent.
Chemical name: (2-hydroxyethyl)trimethylammonium citrate.
(17 Jul 2002)
citrate A salt or ester of citric acid; used as anticoagulants because they bind calcium ions.
(05 Mar 2000)
citrate aldolase Citrate (pro-3S)-lyase;an enzyme that catalyses the cleavage of citrate to oxaloacetate and acetate, in the absence of coenzyme A.
Synonym: citrase, citratase, citrate aldolase, citridesmolase.
(05 Mar 2000)
citrate cleavage enzyme ATP citrate (pro-3S)-lyase
citrate intoxication A toxic condition that may develop during massive replacement therapy with transfused blood that contains citrate as an anticoagulant; the citrate combines with calcium ions and may result in tetany.
(05 Mar 2000)
citrate lyase Citrate (pro-3S)-lyase;an enzyme that catalyses the cleavage of citrate to oxaloacetate and acetate, in the absence of coenzyme A.
Synonym: citrase, citratase, citrate aldolase, citridesmolase.
(05 Mar 2000)
citrate permease <chemical> From lactococcus lactis
(26 Jun 1999)
citrate (pro-3S)-lyase <enzyme> Consists of two enzymes and an acyl carrier protein
Registry number: EC 4.1.3.6
Synonym: citrate lyase
(26 Jun 1999)
citrate (pro-3S)-lyase deacetylase <enzyme> Catalyses conversion of enzymatically active acetyl-s-citrate lyase (4.1.3.6) into inactive hs-form and acetate
Registry number: EC 3.1.2.-
Synonym: citrate lyase deacetylase
(26 Jun 1999)
citrate (pro-3S)-lyase ligase <enzyme> Deacetylcitrate lyase, acetate and ATP forms citrate lyase, AMP, pi
Registry number: EC 6.2.1.22
Synonym: citc gene product, acetate-sh-citrate lyase ligase, citrate lyase ligase
(26 Jun 1999)
citrate (si)-synthase <enzyme> An enzyme of the lyase class that catalyses the condensation of oxaloacetate and the acetyl group of coenzyme a to form citrate and coenzyme a. This is the initial reaction in the tricarboxylic acid cycle.
Chemical name: Citrate oxaloacetate-lyase ((pro-3S)-CH2COO(-)--acetyl-CoA)
Registry number: EC 4.1.3.7
(12 Dec 1998)
citrate synthase Citrate (si)-synthase;an enzyme catalyzing the condensation of oxaloacetate, water, and acetyl-CoA, forming citrate and coenzyme A; an important step in the tricarboxylic acid cycle.
Synonym: citrogenase, condensing enzyme, oxaloacetate transacetase.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á